These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6089633

  • 1. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
    Smith CR, Ambinder R, Lipsky JJ, Petty BG, Israel E, Levitt R, Mellits ED, Rocco L, Longstreth J, Lietman PS.
    Ann Intern Med; 1984 Oct; 101(4):469-77. PubMed ID: 6089633
    [Abstract] [Full Text] [Related]

  • 2. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
    Moore RD, Smith CR, Holloway JJ, Lietman PS.
    Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
    [Abstract] [Full Text] [Related]

  • 3. Cefotaxime and nafcillin-tobramycin.
    Berk SL.
    Ann Intern Med; 1985 Feb; 102(2):275-6. PubMed ID: 3966772
    [No Abstract] [Full Text] [Related]

  • 4. Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides.
    Moore RD, Smith CR, Lietman PS.
    Am J Med; 1986 Jun; 80(6):1093-7. PubMed ID: 3728506
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
    Arich C, Gouby A, Bengler C, Ardilouze JL, Dubois A, Joubert P, Hansel S, Janbon C, Fabre S.
    Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868
    [Abstract] [Full Text] [Related]

  • 6. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.
    Felisart J, Rimola A, Arroyo V, Perez-Ayuso RM, Quintero E, Gines P, Rodes J.
    Hepatology; 1985 May; 5(3):457-62. PubMed ID: 3888810
    [Abstract] [Full Text] [Related]

  • 7. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
    Cox CE.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():47-52. PubMed ID: 6352654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N, van Laethem Y, Vanhoof R, George C, Rapin M, Butzler JP.
    Scand J Infect Dis; 1982 Jul; 14(1):57-60. PubMed ID: 6280269
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
    Alanis A, Rehm S, Weinstein AJ.
    Cleve Clin Q; 1983 Jul; 50(4):385-95. PubMed ID: 6365358
    [No Abstract] [Full Text] [Related]

  • 11. Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.
    Cornely OA, Bethe U, Salzberger B, Franzen C, Hartmann P, Steinmetz T, Fätkenheuer G, Seifert H, Diehl V, Schrappe M.
    Ann Hematol; 2001 Feb; 80(2):103-8. PubMed ID: 11261319
    [Abstract] [Full Text] [Related]

  • 12. Urinary alanine-aminopeptidase (AAP) excretion in patients with urinary tract infection treated with ceftazidime (CAZ) or cefotaxime (CTX) plus tobramycin (TOB).
    Wiecek A, Kokot F, Grzeszczak W.
    Int Urol Nephrol; 1988 Feb; 20(5):461-70. PubMed ID: 2906920
    [Abstract] [Full Text] [Related]

  • 13. Comparative cost effectiveness of gentamicin and tobramycin.
    Holloway JJ, Smith CR, Moore RD, Feroli ER, Lietman PS.
    Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
    [Abstract] [Full Text] [Related]

  • 14. A prospective randomised comparison of cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis.
    Sage R, Nazareth B, Noone P.
    Scand J Infect Dis; 1987 Dec; 19(3):331-7. PubMed ID: 3616496
    [Abstract] [Full Text] [Related]

  • 15. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
    Lawson RD, Gentry LO, Bodey GP, Keating MJ, Smith TL.
    Am J Med Sci; 1984 Dec; 287(1):16-23. PubMed ID: 6367466
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies].
    Wiecek A, Kokot F, Andrzejowska H, Grzeszczak W.
    Pol Tyg Lek; 1986 Sep 29; 41(39):1242-6. PubMed ID: 3547357
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.
    Feld R, Rachlis A, Tuffnell PG, Duncan I, Moran L, Pinfold P, DeBoer G.
    Arch Intern Med; 1984 May 29; 144(5):1005-10. PubMed ID: 6712393
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.
    Chambers HF, Miller RT, Newman MD.
    Ann Intern Med; 1988 Oct 15; 109(8):619-24. PubMed ID: 3421575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.